Boschmann M, Aust L, Frenz U, Noack R
Deutsches Institut für Ernährungsforschung, Potsdam-Rehbrücke, Deutschland.
Ann Nutr Metab. 1996;40(1):10-23. doi: 10.1159/000177893.
Serotoninergic neuronal networks are included in regulation and modification of eating behavior and energy metabolism. Dexfenfluramine (dF), a serotonin releaser and reuptake inhibitor, was used to investigate changes in food intake, body weight development, energy expenditure, respiratory quotient, and substrate oxidation rates for 12 days. Rats which had been made obese by postnatal overfeeding received an energy-controlled mash diet and water ad libitum and were intraperitoneally injected with either saline or 5 or 10 mg dF/kg. As compared with controls, food intake and energy expenditure were significantly decreased in a dose-dependent manner, especially during the first 6 days. Lipid oxidation was increased, while the oxidation of carbohydrates was decreased. The body weight was only slightly reduced after 2 days of dF treatment. After 4 days, dF-treated rats resumed body weight, but as compared with controls both dF groups exhibited lower body weights at the end of the experiment. After 12 days the plasma glucose concentration was unchanged, whereas plasma free fatty acids were significantly decreased. Plasma insulin levels were unchanged after dF, but 10 mg dF/kg led to increased muscle and, especially liver glycogen contents, indicating an improved nonoxidative glucose disposal. Muscle pyruvate kinase was slightly but not significantly increased after dF treatment but that of the liver was significantly decreased, indicating a reduced glycolytic activity of the liver. Whereas the renal N excretion was rather decreased, the plasma concentrations of urea, citrulline, arginine, and ornithine were increased, and the liver contents of glutamine and arginine were decreased. Possibly, there is a shift of ammonia removal from glutamine synthesis to production of urea. The sum of all large neutral amino acids in muscle was significantly decreased after dF treatment, indicating a diminished proteolysis. Pair-feeding experiments over 2 days revealed that this was not solely a result of diminished food intake, but also an additional metabolic effect of dF, different from its anorectic effect. It is concluded that both increased oxidation of endogenous fat and reduced food intake could mediate the body weight reducing effect of dF.
血清素能神经元网络参与进食行为和能量代谢的调节与改变。右芬氟拉明(dF)是一种血清素释放剂和再摄取抑制剂,被用于研究12天内食物摄入量、体重增长、能量消耗、呼吸商以及底物氧化率的变化。通过产后过度喂养而肥胖的大鼠自由摄取能量控制的混合饲料和水,并腹腔注射生理盐水或5或10毫克dF/千克。与对照组相比,食物摄入量和能量消耗以剂量依赖的方式显著降低,尤其是在最初的6天。脂质氧化增加,而碳水化合物氧化减少。dF治疗2天后体重仅略有下降。4天后,dF治疗的大鼠恢复体重,但与对照组相比,两个dF组在实验结束时体重均较低。12天后,血浆葡萄糖浓度未改变,而血浆游离脂肪酸显著降低。dF处理后血浆胰岛素水平未改变,但10毫克dF/千克导致肌肉尤其是肝脏糖原含量增加,表示非氧化葡萄糖处理得到改善。dF治疗后肌肉丙酮酸激酶略有增加但不显著,而肝脏的丙酮酸激酶显著降低,表示肝脏糖酵解活性降低。虽然肾脏氮排泄有所减少,但血浆尿素、瓜氨酸、精氨酸和鸟氨酸浓度增加,肝脏谷氨酰胺和精氨酸含量降低。可能存在氨清除从谷氨酰胺合成向尿素生成的转变。dF治疗后肌肉中所有大中性氨基酸的总和显著降低,表示蛋白水解减少。为期2天的配对喂养实验表明,这不仅是食物摄入量减少的结果,也是dF的一种额外代谢效应,与其厌食效应不同。结论是内源性脂肪氧化增加和食物摄入量减少都可能介导dF的体重减轻作用。